1-3 of 3
Luke Maese, DO
Close
Sort by
Journal Articles

Open-Label, Multicenter, Phase 2/3 Study of Recombinant Crisantaspase Produced in Pseudomonas Fluorescens ( RC-P) in Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Following Hypersensitivity to Escherichia coli -Derived Asparaginases

Luke Maese, DO, Rachel E. Rau, MD, Elizabeth A. Raetz, MD, Tong Lin, Jin Zhu, Pil Kim, Reddy Chandula, Sherrie McClung, Julie Gray, Mi Rim Choi, MD, Mignon L. Loh, MD, Peter C. Adamson
Journal: Blood
Blood (2019) 134 (Supplement_1): 2586.
https://doi.org/10.1182/blood-2019-123710
Published: 2019
Journal Articles

Molecular Features in the Diagnosis of Myeloid Neoplasms in Down Syndrome Patients Less Than Four Years of Age: Experience from a Single Institution

Chris Ours, MD, Fiorella Iglesias, MD, Erin Morales, MD, Luke Maese, DO, Archana M Agarwal, MD, Anupam Verma, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5180.
https://doi.org/10.1182/blood-2018-99-120304
Published: 2018
Journal Articles

Notch Alters Sumoylation To Govern GFI1 Protein Stability and Support Its Transcriptional Repression Function

Jason Singer, PhD, Daniel Andrade, PhD, Diana Bareyan, MS, David McClellan, BS, Helena Lucente, BS, Matthew Velinder, BS, Mahesh Chandrasekharan, PhD, Emily Theisen, BS, Fang Liu, PhD, Sunil Sharma, MD, Luke Maese, DO, Michael E Engel, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3793.
https://doi.org/10.1182/blood.V122.21.3793.3793
Published: 2013